Search Login Register

abatacept (BELATACEPT) Summary

Description: do not confuse with CTLA-4 antigen; inhibits Tumor Necrosis Factor-alpha; used for Rheumatoid Arthritis; inhibits T-cell function without depleting T cells; called a selective costimulator modulator;

Also Known As: BELATACEPT; Orencia; BMS 188667; BMS-188667; BMS-224818 Show All >>

Networked: 541 relevant articles (98 outcomes, 137 trials/studies) for this Drug

Key Diseases for which abatacept is Relevant

  1. Rheumatoid Arthritis : 54 outcomes 75 studies in 292 results
  2. Arthritis (Polyarthritis) : 7 outcomes 8 studies in 20 results
  3. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis) : 5 outcomes 4 studies in 21 results
  4. Uveitis : 5 outcomes 1 study in 12 results
  5. Necrosis : 4 outcomes 13 studies in 35 results
Show All >>

Drugs Related to abatacept

  1. Methotrexate (Mexate)
  2. tocilizumab
  3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  4. abatacept (BELATACEPT)
  5. rituximab (Mabthera)
  6. Antirheumatic Agents (DMARD)
  7. infliximab (Remicade)
  8. Carbon Monoxide
  9. adalimumab (Humira)
  10. TNFR-Fc fusion protein (etanercept)
Show All >>

Therapies Related to abatacept

  1. Aftercare (After-Treatment)
  2. Transplantation (Transplant Recipients)
  3. Transplants (Transplant)
  4. Biological Therapy
  5. Kidney Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.